2-pyrrolino-dox has been researched along with verapamil in 1 studies
Studies (2-pyrrolino-dox) | Trials (2-pyrrolino-dox) | Recent Studies (post-2010) (2-pyrrolino-dox) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
28 | 0 | 2 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanc, E; Castex, C; Clair, P; Merida, P; Rees, AR; Temsamani, J | 1 |
1 other study(ies) available for 2-pyrrolino-dox and verapamil
Article | Year |
---|---|
2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance.
Topics: Adjuvants, Pharmaceutic; Biological Transport; Carrier Proteins; Cell Division; Cell Nucleus; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Gene Expression; Genes, MDR; Humans; Intracellular Fluid; K562 Cells; Pyrroles; Tumor Cells, Cultured; Verapamil | 2004 |